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The Food and Drug Administration’s Center for
Tobacco Products (CTP) oversees the implementation
of the Family Smoking Prevention and Tobacco Control
Act, H.R. 1256. Among its many provisions, section 907
(a) of the Tobacco Control Act banned the use of char-
acterizing flavors, specifically excluding only tobacco
and menthol flavors from the ban. According to section
907(e)(2), “[n]ot later than 1 year after its establishment,
the Tobacco Product Scientific Advisory Committee
shall submit to the Secretary the report and recommen-
dations required pursuant to [menthol],” which, accord-
ing to section 907(e)(1), is “the issue of the impact of
the use of menthol in cigarettes on the public health,
including such use among children, African-Americans,
Hispanics, and other racial and ethnic minorities.” The
inaugural meeting of the Food and Drug Administra-
tion’s Tobacco Products Scientific Advisory Committee
(TPSAC) was held March 30–31, 2010 in Washington,
DC. In preparation for this meeting, CTP reviewed
peer-reviewed literature on menthol and tobacco as
indentified by the National Cancer Institute’s “Bibliogra-
phy of literature on menthol and tobacco”, and seven
scientific presentations were made, including the use of
menthol cigarettes (epidemiology), smoking topography
and sensations associated with menthol cigarettes, mar-
keting of menthol cigarettes, menthol cigarettes and
initiation of smoking behavior, menthol cigarettes and
nicotine dependence, menthol cigarettes and cessation
of tobacco use, and the health effects of menthol cigar-
ettes as compared to non-menthol cigarettes.
Following this initial presentation, additional informa-
tion was collected through FDA investigation, as well as
recommendations from the public, research community
and tobacco industry, resulting in comprehensive
reviews. Thus, this supplement brings together the
extant peer-reviewed information on these seven topics.
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